These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11206941)

  • 1. Chronic urticaria associated with chronic myelomonocytic leukemia.
    Alonso R; Cisteró-Bahíma A; Enrique E; Besses C
    J Investig Allergol Clin Immunol; 2000; 10(6):380-1. PubMed ID: 11206941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose etoposide in the treatment of chronic myelomonocytic leukemia].
    Sato K; Ushijima T; Ohbayashi Y; Sato H; Urabe A
    Rinsho Ketsueki; 1990 Apr; 31(4):521-2. PubMed ID: 2381072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare case of acquired haemophilia in a patient with chronic myelomonocytic leukaemia successfully treated with decitabine.
    Shah D; Kumar R; Gaikazian S
    Haemophilia; 2014 Jan; 20(1):e92-4. PubMed ID: 24261579
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic urticaria associated with thyroid carcinoma: report of 4 cases.
    Manganoni AM; Tucci G; Venturini M; Farisoglio C; Baronchelli C; Calzavara Pinton PG
    J Investig Allergol Clin Immunol; 2007; 17(3):192-5. PubMed ID: 17583108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized granuloma annulare as an initial manifestation of chronic myelomonocytic leukemia: a report of 2 cases.
    Hinckley MR; Walsh SN; Molnár I; Sheehan DJ; Sangueza OP; Yosipovitch G
    Am J Dermatopathol; 2008 Jun; 30(3):274-7. PubMed ID: 18496432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic myelomonocytic leukemia with pleural effusion as the first clinical sign].
    Yamazaki E; Kanai M; Sakai R; Sakamoto H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Mar; 46(3):217-9. PubMed ID: 16447718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia.
    Otrock ZK; Taher AT; Mahfouz RA; Makarem JA; Shamseddine AI
    Am J Hematol; 2006 Mar; 81(3):220-1. PubMed ID: 16493602
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete hematologic remission with oral etoposide in a patient with chronic myelomonocytic leukemia and profound dyserythropoiesis.
    Doll DC; Sun PC; List AF
    Leuk Res; 1994 May; 18(5):381-4. PubMed ID: 8182929
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac tamponade in chronic myelomonocytic leukemia: a case report.
    Yufu Y; Okada Y; Goto T; Nishimura J
    Jpn J Clin Oncol; 1992 Dec; 22(6):411-3. PubMed ID: 1291758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral testicular mass in man with chronic myelomonocytic leukemia: unusual presentation of chronic myelomonocytic leukemia sequela.
    Corcoran NM; Tsui A; Costello AJ; Bouchier-Hayes D
    Urology; 2005 May; 65(5):1001. PubMed ID: 15882745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "handfoot syndrome" occurring with chronic administration of etoposide.
    Schey SA; Cooper J; Summerhayes M
    Eur J Haematol; 1992 Feb; 48(2):118-9. PubMed ID: 1547875
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic myelomonocytic leukemia with low dose etoposide.
    Oscier DG; Worsley A; Hamblin TJ; Mafti GJ
    Br J Haematol; 1989 Jul; 72(3):468-71. PubMed ID: 2765411
    [No Abstract]   [Full Text] [Related]  

  • 13. Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
    Boula AM; Mantadakis E; Xilouri IM; Christoforidou AV; Foudoulakis AM; Samonis G
    Am J Hematol; 2005 Jul; 79(3):216-9. PubMed ID: 15981233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic myelomonocytic leukemia with good response to low-dose etoposide].
    Ando S; Ando S; Otani N; Kanbe T
    Rinsho Ketsueki; 1992 Dec; 33(12):1890-4. PubMed ID: 1479704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic urticaria with ketotifen].
    Guillot B; Meynadier J
    Allerg Immunol (Paris); 1986 Sep; 18(7):33-5. PubMed ID: 2899435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case].
    Zelada J; Cantó G; Berkovits A; Diocares G; López A
    Rev Med Chil; 2015 Nov; 143(11):1490-3. PubMed ID: 26757875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders.
    Niscola P; Siniscalchi A; Tendas A; Scaramucci L; Fratoni S; de Fabritiis P; Caravita T
    Ann Hematol; 2015 Oct; 94(10):1753-4. PubMed ID: 26088814
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential diagnosis of chronic urticaria.
    Brodell LA; Beck LA
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):181-8; quiz 188-90, 215. PubMed ID: 18426134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic urticaria: a report of 233 cases].
    Zaraa I; Sliti N; Ben Kheder Z; El Euch D; Trojjet S; Mokni M; Ben Osman A
    Tunis Med; 2010 Nov; 88(11):794-8. PubMed ID: 21049407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathomimetic amines in the treatment of chronic urticaria: two case reports.
    Check JH; Gentlesk MJ; Falanga V
    Cutis; 1984 Oct; 34(4):388-90. PubMed ID: 6488891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.